Wealth Effects’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$675K Sell
734
-84
-10% -$85.2K 0.24% 81
2025
Q4
$879K Sell
818
-39
-5% -$37.3K 0.27% 64
2025
Q3
$654K Sell
857
-211
-20% -$157K 0.21% 91
2025
Q2
$832K Sell
1,068
-641
-38% -$498K 0.31% 64
2025
Q1
$1.41M Sell
1,709
-268
-14% -$223K 0.59% 38
2024
Q4
$1.53M Sell
1,977
-507
-20% -$420K 0.54% 38
2024
Q3
$2.2M Sell
2,484
-256
-9% -$230K 0.77% 26
2024
Q2
$2.48M Sell
2,740
-74
-3% -$59.2K 0.9% 14
2024
Q1
$2.19M Sell
2,814
-177
-6% -$126K 0.81% 18
2023
Q4
$1.74M Buy
2,991
+841
+39% +$491K 0.66% 26
2023
Q3
$1.15M Buy
2,150
+830
+63% +$428K 0.57% 42
2023
Q2
$619K Buy
1,320
+10
+0.8% +$4.19K 0.27% 79
2023
Q1
$450K Buy
1,310
+280
+27% +$94.4K 0.23% 103
2022
Q4
$377K Buy
1,030
+165
+19% +$58.5K 0.22% 109
2022
Q3
$280K Buy
865
+145
+20% +$45.9K 0.17% 123
2022
Q2
$233K Buy
+720
New +$216K 0.14% 148

Other funds holding LLY

Wealth Effects's LLY Position: Q1 2026 in Review

Wealth Effects reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $85.2K and leaving 734 shares worth $675K. The position accounts for 0.24% of the portfolio, ranked #81.

Wealth Effects first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.48M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Effects held 734 shares of Eli Lilly worth $675K as of Q1 2026.
  • Wealth Effects sold 84 Eli Lilly shares in Q1 2026, an estimated $85.2K.
  • Eli Lilly made up 0.24% of Wealth Effects's portfolio in Q1 2026, its #81 holding.
  • Wealth Effects first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Wealth Effects's Eli Lilly position peaked at $2.48M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.